The risk of gastrointestinal perforation and/or fistula in patients with recurrent ovarian cancer receiving bevacizumab compared to standard chemotherapy: A retrospective cohort study Article

cited authors

  • Sfakianos, Gregory P.; Numnum, T. Michael; Halverson, Caitlin B.; Panjeti, Deepa; Kendrick, James E.; Straughn, J. Michael, Jr.

Publication Date

  • September 1, 2009

webpage

published in

category

keywords

  • Avastin
  • Gastrointestinal fistula
  • Gastrointestinal perforation
  • Recurrent ovarian cancer
  • Retrospective cohort

start page

  • 424

end page

  • 426

volume

  • 114

issue

  • 3